Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Mar 2023 for Pyxis Oncology, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jay Feingold: trading record in brief
Jay Feingold is a declared insider of Pyxis Oncology, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 7 October 2021 to 24 March 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 28 March 2023, the filings show a share grant in Pyxis Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jay Feingold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
209,803 shares0Common StockSEC:0001209191-23-021412:0
53,931 shares0Common StockSEC:0001567619-23-000067:0
115,931 shares0Common StockSEC:0001567619-22-008614:0
306,930 shares0Common StockSEC:0001140361-22-012918:0
43,750 shares0Common StockSEC:0001140361-21-034424:0
5 of 5 declarations
